Skin Allergy Testing Market Forecast for Robust Growth to USD 1,136.83 Million by 2033 at 7.1% CAGR, Anchored by North America's Leadership | Key Players - Thermo Fisher Scientific, Stallergenes Greer, Siemens Healthineers

Leander Texas -
The global Skin allergy testing market size reached US$617.31Million in 2024 from US$579.32Millionin 2023 and is expected to reach US$ 1,136.83Million by 2033, growing at a CAGR of 7.1%during the forecast period 2025-2033.

Market growth is driven by rising allergy prevalence, US regulatory support such as FDA expansions and HollisterStier's facility expansion in Washington, and Japan's advancements like Sysmex's automated allergy platform and Torii Pharmaceutical's research collaborations with Osaka University Hospital.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/skin-allergy-testing-market?prtk

Key Industry Development-

United States: Key Industry Developments
✅ December 2025: Thermo Fisher Scientific expanded its ImmunoCAP skin prick test kits with multiplex allergen panels for rapid in-office diagnostics, enhancing accuracy for food and environmental allergens amid rising pediatric allergy cases.
​
✅ October 2025: HYCOR Biomedical launched an upgraded NIAID-supported skin testing device integrating AI for real-time reaction analysis, reducing false positives by 25% in clinical trials for contact dermatitis.
​
✅ September 2025: StallERGENES Greer received FDA clearance for the Skintestor OMNI 2.0 applicator, improving precision in intradermal testing for occupational skin allergies in high-risk U.S. workers.

Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Sysmex Corporation introduced a point-of-care skin patch test system for common Japanese allergens like pollen and cosmetics, supported by MHLW subsidies for outpatient clinics.
​
✅ August 2025: LSI Medience collaborated on a biosensor-enhanced prick test kit for multiplex allergy screening, targeting urban pollution-related skin reactions in Tokyo demographics.
​
✅ June 2025: Japanese firm Proteomtech rolled out an advanced Allergy-Q panel adapted for skin testing 128 allergens simultaneously, approved by PMDA for enhanced contact allergy diagnostics.

Strategic Mergers and Acquisitions:

In November 2025, Thermo Fisher Scientific announced it would acquire Clario Holdings, a data management and endpoint solutions provider, in a transaction valued at US $8.88 billion. While Clario is broader than skin allergy testing, the deal strengthens Thermo Fisher's diagnostics portfolio - including immunodiagnostic and clinical testing capabilities that underpin allergy testing platforms used in clinical settings.

Also in November 2025, Abbott Laboratories agreed to acquire Exact Sciences Corporation for approximately US $21 billion (equity value) - with an enterprise value near US $23 billion. Although Exact Sciences is a molecular diagnostics firm focused on cancer screening, this megadeal reflects broader diagnostics consolidation that impacts companies offering diagnostic reagents and testing platforms, including allergy testing segments.

In November 2025, ALK-Abelló A/S completed the acquisition of Era Biology Co. Ltd, a move explicitly aimed at expanding its antigen and allergy skin test footprint, particularly in Asia. This transaction strengthens ALK-Abelló's position in global skin diagnostic tests with a broader reagent and antigen portfolio that supports in vivo skin allergy diagnostics.

Major Players:-
Thermo Fisher Scientific | Stallergenes Greer | Siemens Healthineers | Allergy Therapeutics | ALK | HYCOR Biomedical

1. Thermo Fisher Scientific
Thermo Fisher Scientific leads the market with its comprehensive ImmunoCAP and Phadia allergy testing systems, regarded globally as the gold-standard in specific IgE diagnostics. Its broad product portfolio, strong R&D, and wide geographic reach drive high adoption in clinical labs worldwide.

2. Stallergenes Greer
Stallergenes Greer is prominent for its focus on allergen immunotherapy and related diagnostics. With global presence in 45+ countries, it integrates skin test reagents with immunotherapy solutions and invests in precision allergy diagnostics, helping strengthen its position in both clinical and therapeutic segments.

3. Siemens Healthineers
Siemens Healthineers stands out with advanced automated immunodiagnostic platforms offering broad allergen test menus and high throughput. Its strong investment in laboratory automation and digital workflows enhances efficiency and reliability for allergy testing in hospitals and central labs.

4. Allergy Therapeutics
Allergy Therapeutics specialises in allergy diagnosis and treatment development, including immunotherapy vaccines that go beyond symptom management. Its established European commercial presence and R&D pipeline in allergen immunotherapy strengthen its foothold in allergy diagnostics and therapeutic integration.

5. ALK
ALK-Abelló has over 100 years of allergy expertise, offering diagnostic skin prick devices and allergen trays alongside leading immunotherapy products. Its innovative skin testing tools (e.g., AccuTest) enhance precision and patient comfort, reinforcing its market reputation.

"Secure your 30% discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=skin-allergy-testing-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

1. Segmentation by Test Type: In both the U.S. and Japan, skin allergy testing is broken down by test methodology, including prick tests, intradermal tests, and patch tests. In the U.S., intradermal testing holds the largest share of the antigen/skin test segment due to its high sensitivity for detecting hypersensitivity reactions, while patch tests are growing fastest driven by awareness of contact dermatitis. Japan's market similarly uses these primary in-vivo methods as core diagnostic approaches, though detailed country breakdowns specifically by test type are less frequently published than in the U.S. due to smaller overall market size.

2. Segmentation by Application/Allergen Type: The market in the United States often segments tests by allergen categories (e.g., environmental, food, medication) and clinical applications like allergic rhinitis and drug allergies, with environmental and food allergies driving diagnostic demand. In Japan, market data suggests growth across general allergy diagnostics driven by rising allergy prevalence and clinical guidelines for comprehensive diagnosis, though specific allergen type shares are less granular than U.S. datasets.

3. Segmentation by End User: End users in the U.S. include hospitals, diagnostic laboratories, and specialist clinics, with hospitals traditionally dominating due to inpatient allergy care infrastructure and high patient volumes for diagnostic procedures. Japan's segment is increasingly centered around hospital and clinic settings supported by clinical best practice guidance, with diagnostic centers also expanding as allergy awareness grows in urban populations.

Market Drivers:-

• Rising Prevalence of Allergic Disorders in the U.S. and Japan: In the U.S., over 50 million people experience allergies annually, according to the Asthma and Allergy Foundation of America, driving demand for skin prick and patch testing. In Japan, increasing cedar pollen sensitization reported by the Ministry of Health, Labour and Welfare is accelerating diagnostic testing adoption.

• Growing Environmental and Seasonal Allergen Exposure: In the U.S., extended pollen seasons linked to climate variability have increased allergic rhinitis cases, boosting in-clinic testing volumes. In Japan, widespread sugi (cedar) pollen exposure-affecting nearly 30-40% of the population-has significantly expanded demand for confirmatory skin allergy diagnostics.

• Technological Advancements in Diagnostic Devices: U.S.-based manufacturers are introducing standardized, FDA-cleared multi-allergen testing panels, improving accuracy and turnaround time. In Japan, domestic diagnostic firms are enhancing automated allergen extract systems, supporting hospitals and ENT clinics with more precise and reproducible skin test procedures.

• Expanding Insurance Coverage and Reimbursement Support: In the U.S., Medicare and private insurers reimburse percutaneous and intradermal allergy testing, improving patient access. Japan's universal health insurance system covers allergy diagnostics under national reimbursement schedules, encouraging early-stage testing in outpatient and specialty care settings.

• Increasing Pediatric and Geriatric Allergy Screening: Rising pediatric food allergies in the U.S., highlighted by the Centers for Disease Control and Prevention, are strengthening early diagnostic screening demand. In Japan, the aging population with respiratory sensitivities is prompting routine allergy assessments in primary and pulmonary care facilities.

Regional insights:-

North America (incl. U.S.): 40.8% - Dominant share, led by U.S. demand due to high allergy prevalence, advanced diagnostics infrastructure and reimbursement access.

Asia Pacific (incl. Japan): 23% - Significant contribution with fastest growth, driven by rising awareness, healthcare expansion and urban allergic conditions (Japan is part of this regional mix; separate country share 2.3% of global allergy diagnostics)

Europe: 28% - Solid second position with growing adoption of skin allergy diagnostics and structured clinical screening programs.

Latin America + Middle East & Africa: 9.5% combined - Smaller but emerging market segments relative to the global skin allergy testing industry.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/skin-allergy-testing-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.